US Indicts Nigerian Man in $14 Billion Healthcare Fraud Case

US Indicts Nigerian in $14 Billion Healthcare Fraud Case

The United States Department of Justice has indicted a Nigerian national, Olatunbosun Osukoya, along with 323 others, in connection with an alleged healthcare fraud scheme that targeted federal insurance programs and resulted in over \$14 billion in intended losses.

According to a statement released on Thursday, the DOJ announced charges against 324 individuals, including 96 doctors, nurse practitioners, pharmacists, and other licensed medical professionals across 50 federal districts and 12 State Attorneys General’s Offices. The coordinated crackdown, known as the 2025 National Health Care Fraud Takedown, exposed what authorities described as widespread exploitation of patients and taxpayers.

Among those indicted, Osukoya, 67, was highlighted for his alleged role in orchestrating a multimillion-dollar fraud scheme. As the owner of Cambridge Diagnostics, operating under the name Ayo Biometrics, LLC, the Plano, Texas-based businessman was accused of submitting more than \$25 million in false medical claims to Medicare, TRICARE, and other insurers.

Federal prosecutors allege that Osukoya recruited individuals with insurance coverage for costly EEG testing and paid bribes to medical professionals in exchange for patient referrals. To disguise the fraud, he and his associates reportedly falsified medical diagnoses and masked illegal payments as loans, consultation fees, or medical directorships. The DOJ further stated that Osukoya received over \$5 million in reimbursements and paid out more than \$450,000 in illegal kickbacks.

Meanwhile, in a related development, a France-based Nigerian man, Newton Ofioritse Jemide, was sentenced to three years and five months in a U.S. federal prison after being extradited to face charges in an \$8 million disaster fraud case. Jemide had fraudulently secured federal relief funds intended for vulnerable Americans and was sentenced by Judge Deborah K. Chasanow earlier this week.

The DOJ emphasized its continued efforts to root out health care fraud and protect public funds, noting the scope and severity of the alleged schemes uncovered in the latest enforcement action.